Qube Research & Technologies LTD Lexicon Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.06 - $2.33 $216,245 - $475,331	204,005 Added 278.53%	277,248 $302,000
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $26,918 - $43,694	12,520 Added 20.62%	73,243 $167,000
Q1 2023 May 15, 2023	BUY	$1.99 - $2.68 $120,838 - $162,737	60,723 New	60,723 $147,000
Q2 2021 Aug 13, 2021	SELL	$4.12 - $5.87 $84,418 - $120,276	-20,490 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$3.45 - $9.09 $70,690 - $186,254	20,490 New	20,490 $120,000
Q2 2020 Aug 14, 2020	SELL	$1.75 - $2.3 $51,070 - $67,120	-29,183 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.8 - $4.28 $52,529 - $124,903	29,183 New	29,183 $57,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.